← Eichor
Condition: Vaccine Prophylaxis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Vaccine Prophylaxis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
Phase 1 · 5 location(s) · Institute for Molecular Medicine · NCT07158905Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07252804Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Compl
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire de la Réunion · NCT06928753Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Inte
Phase 3 · 1 location(s) · Fujian Medical University Union Hospital · NCT06441110Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC
Phase 2/Phase 3 · 1 location(s) · Second Affiliated Hospital of Wenzhou Medical University · NCT06341907HPV Vaccine Reduced Dose
Phase 4 · 1 location(s) · Emory University · NCT06799494A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Pr
Phase 1 · 3 location(s) · International AIDS Vaccine Initiative · NCT07565090Integration to Improve Adolescent Health and HPV Vaccination in Laos
NA · 1 location(s) · Health Poverty Action · NCT06650956Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients
Phase 4 · 1 location(s) · Children's Mercy Hospital Kansas City · NCT07195032Real World Evidence Study of SYN023 in Children Exposed to Rabies
Phase N/A · 6 location(s) · Synermore Biologics (Suzhou) Co., Ltd. · NCT07327307Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06881953An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolesce
Phase 3 · 3 location(s) · Bavarian Nordic · NCT07467707PCOM2 - The Physician Communication Intervention, Version 2.0
NA · 2 location(s) · University of Colorado, Denver · NCT05336240Factors Affecting Vaccine Prophylaxis Efficacy in Bone Marrow and Solid Organ Transplant Recipients: Impact on Infection
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07473999Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in
Phase 4 · 1 location(s) · Epicentre · NCT07038837Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia
Phase 4 · 2 location(s) · Tor Biering-Sørensen · NCT07485283Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
Phase 2 · 4 location(s) · Dynavax Technologies Corporation · NCT07207408Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT
Phase 4 · 10 location(s) · McMaster University · NCT05745987Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
Phase 1 · 2 location(s) · Aribio Lab Co., Ltd. · NCT06137755ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
NA · 1 location(s) · University of Florida · NCT06535139Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07087912Screening Volunteers for Clinical Trials
Phase N/A · 4 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01375530A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney
Phase 1/Phase 2 · 31 location(s) · GlaxoSmithKline · NCT04006808XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Ac
EARLY_Phase 1 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06980155Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07111078Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
Phase 1 · 1 location(s) · HDT Bio · NCT06799013Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06863142Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06885853Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Phase 1 · 5 location(s) · National Cancer Institute (NCI) · NCT05985681A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Pa
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT07020533
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.